Medicine
Fluorescite 500 mg/5 mL injection
Fluorescite 500 mg/5 mL injection is a prescription medicine containing Fluorescein for ophthalmic use, marketed by Alcon, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Do Not Freeze Store at 2°to 25°C (36° to 77°F).
Key facts
- Active ingredient (INN)
- Fluorescein
- Brand
- Fluorescite
- Strength
- 500 mg/5 mL
- Dosage form
- Injection
- Route
- Ophthalmic
- Packs
- 12 vials of 5 mL
- Marketing authorisation holder
- Alcon
- Manufacturer
- Alcon
- Origin register
- US FDA, United States
- Storage
- Do Not Freeze Store at 2°to 25°C (36° to 77°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- S01JA01 Fluorescein
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 15 September 1972
- Identifiers
- DailyMed set ID ebb3883c-71f6-4fd0-a7e6-0ba8e1136dd9NDC 0065-0092Application NDA021980
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 12 vial in 1 carton / 5 mL in 1 vial | 0065-0092-65 | Alcon | 15 September 1972 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 10 November 1976 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Fluorescein 500 mg/5 mL injection.
Other strengths and forms of Fluorescein
Clinical summary
Fluorescein is a diagnostic dye indicated in diagnostic fluorescein angiography or angioscopy of the retina and iris vasculature. It is available as injection for intravenous and ophthalmic use. MedsAcross supplies Fluorescein for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about FluoresceinFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- FLUORESCITE prescribing information (Alcon) · U.S. National Library of Medicine, DailyMed
Need Fluorescite 500 mg/5 mL injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.